Leap Therapeutics Inc (LPTX) Event May 13, 2022, 11:10 UTC 19 1 comments (10% Negative) Leap Therapeutics, Inc. (LPTX) Reports Q2 2022 Financial Results Comment Full text
Humacyte Inc (HUMA) Event May 13, 2022, 11:03 UTC 19 1 comments (30% Negative) Humacyte, Inc. (HUMA) Reports Q2 2022 Financial Results Comment Full text
Leap Therapeutics Inc (LPTX) Event May 13, 2022, 00:00 UTC 27 1 comments (76% Positive) LEAP THERAPEUTICS, INC. (LPTX) Reports Net Loss for 2022-03-31 Comment Full text
Humacyte Inc (HUMA) Event May 13, 2022, 00:00 UTC 30 1 comments (52% Neutral) Humacyte, Inc. (HUMA) Reports Net Loss for 2022-03-31 Comment Full text
Travere Therapeutics, Inc (TVTX) Event May 12, 2022, 21:26 UTC 17 1 comments (10% Negative) TRAVERE THERAPEUTICS, INC. (TVTX) Files Form 8-K Comment Full text
BioNTech SE (BNTX) Event May 12, 2022, 21:18 UTC 16 1 comments (10% Negative) BioNTech SE (BNTX) Announces Clinical Development Update (Form 6-K) Comment Full text
Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX) Event May 12, 2022, 21:12 UTC 19 1 comments (10% Negative) CORTEXYME, INC. (CRTX) Reports Q2 2022 Financial Results Comment Full text
MannKind Corporation (MNKD) Event May 12, 2022, 21:12 UTC 19 1 comments (99% Neutral) MannKind Corporation (MNKD) Announces Regulatory Update Comment Full text
Mirati Therapeutics Inc (was acquisied by Bristol Myers Squibb (NYSE: BMY) on 23/01/2024) (MRTX) Event May 12, 2022, 21:07 UTC 19 1 comments (80% Positive) MIRATI THERAPEUTICS, INC. (MRTX) Files Form 8-K Comment Full text
Cellectis (CLLS) Event May 12, 2022, 20:48 UTC 18 1 comments (10% Negative) Cellectis (CLLS) Reports Q2 2022 Financial Results (Form 6-K) Comment Full text